These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 24635625)

  • 1. The path of malaria vaccine development: challenges and perspectives.
    Arama C; Troye-Blomberg M
    J Intern Med; 2014 May; 275(5):456-66. PubMed ID: 24635625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria vaccines: focus on adenovirus based vectors.
    Schuldt NJ; Amalfitano A
    Vaccine; 2012 Jul; 30(35):5191-8. PubMed ID: 22683663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
    Stoute JA; Slaoui M; Heppner DG; Momin P; Kester KE; Desmons P; Wellde BT; Garçon N; Krzych U; Marchand M
    N Engl J Med; 1997 Jan; 336(2):86-91. PubMed ID: 8988885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria vaccines: are we getting closer?
    Epstein JE; Giersing B; Mullen G; Moorthy V; Richie TL
    Curr Opin Mol Ther; 2007 Feb; 9(1):12-24. PubMed ID: 17330398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Plasmodium sporozoite survives RTS,S vaccination.
    Snounou G; Grüner AC; Müller-Graf CD; Mazier D; Rénia L
    Trends Parasitol; 2005 Oct; 21(10):456-61. PubMed ID: 16109504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole organism blood stage vaccines against malaria.
    Stanisic DI; Good MF
    Vaccine; 2015 Dec; 33(52):7469-75. PubMed ID: 26428451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing malaria vaccines to circumvent antigen variability.
    Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
    Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A whole parasite vaccine to control the blood stages of Plasmodium: the case for lateral thinking.
    Good MF
    Trends Parasitol; 2011 Aug; 27(8):335-40. PubMed ID: 21514227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunity.
    Mitchell RA; Altszuler R; Frevert U; Nardin EH
    Sci Rep; 2016 Sep; 6():32575. PubMed ID: 27624667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities.
    Luo K; Zhang H; Zavala F; Biragyn A; Espinosa DA; Markham RB
    PLoS One; 2014; 9(3):e90413. PubMed ID: 24599116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of whole sporozoite malaria vaccines.
    Hollingdale MR; Sedegah M
    Expert Rev Vaccines; 2017 Jan; 16(1):45-54. PubMed ID: 27327875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for a subunit vaccine against malaria.
    Anders RF
    Trends Parasitol; 2011 Aug; 27(8):330-4. PubMed ID: 21592861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RTS,S/AS02A for malaria.
    Bojang KA
    Expert Rev Vaccines; 2006 Oct; 5(5):611-5. PubMed ID: 17181435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vaccination against malaria. Disappointments and hopes].
    Ambroise-Thomas P
    Bull Acad Natl Med; 1997 Nov; 181(8):1637-48; discussion 1648-50. PubMed ID: 9554123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-erythrocytic malaria vaccines: towards greater efficacy.
    Hill AV
    Nat Rev Immunol; 2006 Jan; 6(1):21-32. PubMed ID: 16493425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preerythrocytic malaria vaccine development.
    Mikolajczak SA; Aly AS; Kappe SH
    Curr Opin Infect Dis; 2007 Oct; 20(5):461-6. PubMed ID: 17762778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling.
    Cai Q; Peng G; Bu L; Lin Y; Zhang L; Lustigmen S; Wang H
    Vaccine; 2007 Jul; 25(28):5155-65. PubMed ID: 17548134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.